Dietary Curcumin: Correlation Between Bioavailability and Health Potential

Overview

Journal Nutrients

Date 2019 Sep 11

PMID 31500361

Citations 182

Authors

Michele Dei Cas

Riccardo Ghidoni

Affiliations

Soon will be listed here.

Abstract

The yellow pigment curcumin, extracted from turmeric, is a renowned polyphenol with a broad spectrum of health properties such as antioxidant, anti-inflammatory, anti-cancer, antidiabetic, hepatoprotective, anti-allergic, anti-dermatophyte, and neuroprotective. However, these properties are followed by a poor pharmacokinetic profile which compromises its therapeutic potential. The association of low absorption by the small intestine and the extensive reductive and conjugative metabolism in the liver dramatically weakens the oral bioavailability. Several strategies such as inhibition of curcumin metabolism with adjuvants as well as novel solid and liquid oral delivery systems have been tried to counteract curcumin poor absorption and rapid elimination from the body. Some of these drug deliveries can successfully enhance the solubility, extending the residence in plasma, improving the pharmacokinetic profile and the cellular uptake.

Citing Articles

Synergistic Neuroprotection Through Epigenetic Modulation by Combined Curcumin-Enriched Turmeric Extract and L-Ascorbic Acid in Oxidative Stress-Induced SH-SY5Y Cell Damage.

Khongrum J, Mairuae N, Thanchomnang T, Zhang M, Bai G, Palachai N Foods. 2025; 14(5).

PMID: 40077595 PMC: 11898916. DOI: 10.3390/foods14050892.

Mitigating doxorubicin-induced hepatotoxicity in male rats: The role of aerobic interval training and curcumin supplementation in reducing oxidative stress, endoplasmic reticulum stress and apoptosis.

Zobeydi A, Mousavi Namavar S, Sadeghi Shahdani M, Choobineh S, Kordi M, Rakhshan K Sci Rep. 2025; 15(1):6604.

PMID: 39994295 PMC: 11850886. DOI: 10.1038/s41598-025-91133-6.

HOO radical scavenging activity of curcumin I and III in physiological conditions: a theoretical investigation on the influence of acid-base equilibrium and tautomerism.

Truong D, Dinh T, Trinh T, Pham T, Pham M, Gawlik-Dziki U RSC Adv. 2025; 15(8):5649-5664.

PMID: 39990812 PMC: 11843644. DOI: 10.1039/d4ra07769e.

Exploring the role of curcumin in mitigating oxidative stress to alleviate lipid metabolism disorders.

Cheng M, Ding F, Li L, Dai C, Sun X, Xu J Front Pharmacol. 2025; 16:1517174.

PMID: 39950117 PMC: 11822302. DOI: 10.3389/fphar.2025.1517174.

The beneficial effects of curcumin on aging and age-related diseases: from oxidative stress to antioxidant mechanisms, brain health and apoptosis.

He Y, Liu Y, Zhang M Front Aging Neurosci. 2025; 17:1533963.

PMID: 39906716 PMC: 11788355. DOI: 10.3389/fnagi.2025.1533963.

References

Schiborr C, Kocher A, Behnam D, Jandasek J, Toelstede S, Frank J . The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol Nutr Food Res. 2014; 58(3):516-27. DOI: 10.1002/mnfr.201300724. View

Liu A, Lou H, Zhao L, Fan P . Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. J Pharm Biomed Anal. 2005; 40(3):720-7. DOI: 10.1016/j.jpba.2005.09.032. View

Hassaninasab A, Hashimoto Y, Tomita-Yokotani K, Kobayashi M . Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proc Natl Acad Sci U S A. 2011; 108(16):6615-20. PMC: 3080977. DOI: 10.1073/pnas.1016217108. View

Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K . Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother Pharmacol. 2011; 69(1):65-70. DOI: 10.1007/s00280-011-1673-1. View

Lim L, Tran T, Long Wong J, Wang D, Cheow W, Hadinoto K . Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin. Colloids Surf B Biointerfaces. 2018; 167:483-491. DOI: 10.1016/j.colsurfb.2018.04.049. View

Carroll R, Benya R, Turgeon D, Vareed S, Neuman M, Rodriguez L . Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila). 2011; 4(3):354-64. PMC: 4136551. DOI: 10.1158/1940-6207.CAPR-10-0098. View

Li R, Wang Y, Liu Y, Chen Q, Fu W, Wang H . Curcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cells. PLoS One. 2013; 8(3):e58848. PMC: 3609782. DOI: 10.1371/journal.pone.0058848. View

Lin J, Huo X, Liu X . "mTOR Signaling Pathway": A Potential Target of Curcumin in the Treatment of Spinal Cord Injury. Biomed Res Int. 2017; 2017:1634801. PMC: 5485291. DOI: 10.1155/2017/1634801. View

Thacker P, Karunagaran D . Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells. PLoS One. 2015; 10(3):e0120045. PMC: 4365016. DOI: 10.1371/journal.pone.0120045. View

10.

Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P . Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998; 64(4):353-6. DOI: 10.1055/s-2006-957450. View

11.

Lestari M, Indrayanto G . Curcumin. Profiles Drug Subst Excip Relat Methodol. 2014; 39:113-204. DOI: 10.1016/B978-0-12-800173-8.00003-9. View

12.

Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T . Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull. 2011; 34(5):660-5. DOI: 10.1248/bpb.34.660. View

13.

Nelson K, Dahlin J, Bisson J, Graham J, Pauli G, Walters M . The Essential Medicinal Chemistry of Curcumin. J Med Chem. 2017; 60(5):1620-1637. PMC: 5346970. DOI: 10.1021/acs.jmedchem.6b00975. View

14.

Antony B, Merina B, Iyer V, Judy N, Lennertz K, Joyal S . A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin. Indian J Pharm Sci. 2010; 70(4):445-9. PMC: 2792534. DOI: 10.4103/0250-474X.44591. View

15.

Dutzmann S, Schiborr C, Kocher A, Pilatus U, Hattingen E, Weissenberger J . Intratumoral Concentrations and Effects of Orally Administered Micellar Curcuminoids in Glioblastoma Patients. Nutr Cancer. 2016; 68(6):943-8. DOI: 10.1080/01635581.2016.1187281. View

16.

Esatbeyoglu T, Huebbe P, Ernst I, Chin D, Wagner A, Rimbach G . Curcumin--from molecule to biological function. Angew Chem Int Ed Engl. 2012; 51(22):5308-32. DOI: 10.1002/anie.201107724. View

17.

Peng S, Li Z, Zou L, Liu W, Liu C, McClements D . Enhancement of Curcumin Bioavailability by Encapsulation in Sophorolipid-Coated Nanoparticles: An in Vitro and in Vivo Study. J Agric Food Chem. 2018; 66(6):1488-1497. DOI: 10.1021/acs.jafc.7b05478. View

18.

Gordon O, Luis P, Sintim H, Schneider C . Unraveling curcumin degradation: autoxidation proceeds through spiroepoxide and vinylether intermediates en route to the main bicyclopentadione. J Biol Chem. 2015; 290(8):4817-4828. PMC: 4335222. DOI: 10.1074/jbc.M114.618785. View

19.

Begum A, Jones M, Lim G, Morihara T, Kim P, Heath D . Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther. 2008; 326(1):196-208. PMC: 2527621. DOI: 10.1124/jpet.108.137455. View

20.

Morimoto T, Sunagawa Y, Katanasaka Y, Hirano S, Namiki M, Watanabe Y . Drinkable preparation of Theracurmin exhibits high absorption efficiency--a single-dose, double-blind, 4-way crossover study. Biol Pharm Bull. 2013; 36(11):1708-14. DOI: 10.1248/bpb.b13-00150. View